VIROLOGICAL ANALYSIS OF PATIENTS RECEIVING TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE PATIENTS WITH GENOTYPE 1 HEPATITIS C: STUDY C208

被引：0
|
作者：
Marcellin, Patrick [1 ]
Forns, Xavier [2 ]
Goeser, Tobias [3 ]
Ferenci, Peter [4 ]
Nevens, Frederik [5 ]
Carosi, Giampiero [6 ]
Drenth, Joost P. [7 ]
De Backer, Koen [8 ]
van Heeswijk, Rudolf [8 ]
Luo, Donghan [9 ]
Picchio, Gaston [9 ]
Beumont-Mauviel, Maria [8 ]
机构：
[1] Hop Beaujon, Liver Unit, Clichy, France
[2] Univ Barcelona, Barcelona, Spain
[3] Klinikum Univ Koln, Cologne, Germany
[4] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Leuven, Belgium
[6] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy
[7] Radboud Univ Nijmegen, Ctr Med, NL-6525 ED Nijmegen, Netherlands
[8] Tibotec BVBA, Mechelen, Belgium
[9] Tibotec Inc, Yardley, PA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
194
引用
收藏
页码：395A / 395A
页数：1
相关论文
共 50 条
  • [31] Treatment of Insulin Resistance with Metformin in Naive Genotype 1 Chronic Hepatitis C Patients Receiving Peginterferon Alfa-2a Plus Ribavirin
    Romero-Gomez, Manuel
    Diago, Moises
    Andrade, Raul J.
    Calleja, Jose L.
    Salmeron, Javier
    Fernandez-Rodriguez, Conrado M.
    Sola, Ricard
    Garcia-Samaniego, Javier
    Herrerias, Juan M.
    De la Mata, Manuel
    Moreno-Otero, Ricardo
    Nunez, Oscar
    Olveira, Antonio
    Duran, Santiago
    Planas, Ramon
    HEPATOLOGY, 2009, 50 (06) : 1702 - 1708
  • [32] Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virological Response
    Pearlman, Brian L.
    Ehleben, Carole
    HEPATOLOGY, 2010, 52 (04) : 1519 - 1520
  • [33] Viral kinetics and pharmacodynamics of albinterferon alfa-2b in interferon treatment-NaiVe patients with genotype 1, chronic hepatitis C
    Neumann, Avidan U.
    Rozenberg, Lynn
    Bain, Vincent G.
    McHutchison, John G.
    Pulkstenis, Erik
    Subramanian, Mani
    GASTROENTEROLOGY, 2008, 134 (04) : A788 - A788
  • [34] Prove1: Results from a phase 2 study of telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive subjects with hepatitis C
    Everson, Gregory T.
    Jacobson, Ira M.
    Gordon, Stuart C.
    McHutchison, John G.
    Kaufman, Robert
    McNair, Lindsay
    Muir, Andrew
    GASTROENTEROLOGY, 2008, 134 (04) : A758 - A758
  • [35] Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C
    Neumann, Avidan U.
    Pianko, Stephen
    Zeuzem, Stefan
    Yoshida, Eric M.
    Benhamou, Yves
    Mishan, Moshe
    McHutchison, John G.
    Pulkstenis, Erik
    Subramanian, G. Mani
    JOURNAL OF HEPATOLOGY, 2009, 51 (01) : 21 - 28
  • [36] Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study
    Bruno, R.
    Sacchi, P.
    Scagnolari, C.
    Torriani, F.
    Maiocchi, L.
    Patruno, S.
    Bellomi, F.
    Filice, G.
    Antonelli, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 369 - 376
  • [37] EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAIVE, CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS
    Zeuzem, S.
    Sulkowski, M.
    Lawitz, E.
    Rustgi, V.
    Lurie, Y.
    Grigorescu, M.
    Muir, A.
    Cronin, P.
    Pulkstenis, E.
    Subramanian, M.
    McHutchison, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S377 - S377
  • [38] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [39] Telaprevir plus peginterferon alfa-2a and ribavirin in treatment-naive patients with genotype 1 HCV and mild to moderate liver disease
    Zeuzem, Stefan
    DeMasi, Ralph
    Foster, Graham R.
    Buti, Maria
    Laeuffer, Joerg M.
    Luo, Donghan
    Witek, James
    Rizzetto, Mario
    HEPATOLOGY, 2013, 58 : 1129A - 1129A
  • [40] Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
    Liu, Chen-Hua
    Liu, Chun-Jen
    Huang, Chung-Feng
    Lin, Jou-Wei
    Dai, Chia-Yen
    Liang, Cheng-Chao
    Huang, Jee-Fu
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Tsai, Meng-Kun
    Lee, Chih-Yuan
    Chen, Shih-I
    Yang, Sheng-Shun
    Su, Tung-Hung
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Chuang, Wan-Long
    Yu, Ming-Lung
    Kao, Jia-Horng
    GUT, 2015, 64 (02) : 303 - 311
12345